TABLE 3.
Univariate analysis of overall survival in TCGA.
Parameters | HR | HR.95L | HR.95H | P-value |
Age | 1.010238 | 0.995394 | 1.025303 | 0.177451 |
Gender | 0.82049 | 0.557003 | 1.208619 | 0.316744 |
Grade | 1.120516 | 0.868279 | 1.446029 | 0.381849 |
Stage | 1.671825 | 1.359423 | 2.056017 | 1.12E−06 |
T | 1.651769 | 1.356646 | 2.011093 | 5.82E−07 |
BIRC5 | 1.390493 | 1.202188 | 1.608294 | 8.99E−06 |
FOXM1 | 1.388131 | 1.175026 | 1.639885 | 0.000115 |
CENPA | 1.803812 | 1.471493 | 2.21118 | 1.36E−08 |
KIF4A | 1.461444 | 1.227241 | 1.740342 | 2.06E−05 |
DTYMK | 1.68016 | 1.3456 | 2.097902 | 4.65E−06 |
PRC1 | 1.355446 | 1.122636 | 1.636537 | 0.001561 |
IGF2BP3 | 1.576372 | 1.212821 | 2.048901 | 0.000668 |
KIF2C | 1.600898 | 1.343936 | 1.906991 | 1.35E−07 |
TRIP13 | 1.726845 | 1.415869 | 2.106122 | 6.94E−08 |
TPX2 | 1.48561 | 1.265967 | 1.74336 | 1.24E−06 |
HR, hazard ratio; TCGA, The Cancer Genome Atlas.